Scientists at Fralin Biomedical Research Institute develop new strategy for brain cancer treatment
Category: research Video duration: Scientists at Fralin Biomedical Research Institute develop new strategy for brain cancer treatment
In a new study published in Oncogenesis, Zhi Sheng and Rob Gourdie of the Fralin Biomedical Research Institute at VTC describe how two protein-targeting drugs – when combined with chemotherapy – yield synergistic cytotoxicity to treatment-resistant glioblastoma.
What we're watching is cancer that occurred in the brain called glioblastoma. Have this tumor your lifespan? Would it be just in average? What we are trying to do is to identify new therapy that could tackle this disease. We found two drugs currently use in other diseases. And all which combine those two together with the chemo therapy CO2 Mazola might we found that we can cure cancer cells, particularly brain cancer cell very effective. The most encouraging part for this research is that it's not just down by our lab, is, but is done by collaborations of researchers from different research background. I believe this kind of multidisciplinary research collaboration. To me, that's the most exciting part for scientific research because it will definitely lead to more innovative and a normal findings, particularly in, to me in cancer research and also help, Yes.